Matthew Franklin's most recent trade in Akili Inc was a trade of 1,615 Common Stock done at an average price of $0.3 . Disclosure was reported to the exchange on March 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Akili Inc | Matthew Franklin | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.34 per share. | 10 Mar 2024 | 1,615 | 752,283 | - | 0.3 | 549 | Common Stock |
Akili Inc | Matthew Franklin | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
Akili Inc | Matthew Franklin | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 44,000 | 755,626 | - | - | Common Stock | |
Akili Inc | Matthew Franklin | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 973,234 | 973,234 | - | - | Stock Option (Right to Buy) | |
Akili Inc | Matthew Franklin | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 711,626 | 711,626 | - | - | Common Stock |